ArticleMedicine2026
Impact of a two-dose varicella vaccination strategy and public health measures on varicella incidence in Shengzhou City: An interrupted time series study.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aims to evaluate the impact of a two-dose varicella vaccine immunization strategy and public health and social measures (PHSMs) on varicella incidence in Shengzhou City. In this study, PHSMs are defined as non-pharmaceutical interventions - including social distancing, school closures, and case isolation - implemented during the COVID-19 pandemic. Data on reported varicella cases in Shengzhou City from 2006 to 2022 were collected, and interrupted time series regression models were constructed to assess changes in monthly varicella incidence rates during the periods of the one-dose strategy, the two-dose strategy, and the implementation of PHSMs. Interrupted time series analyses showed a significant immediate reduction in monthly varicella incidence of 0.754 per 100,000 (P = .023) following the introduction of the two-dose varicella vaccine strategy. A further immediate reduction of 1.363 per 100,000 (P = .001) occurred after the implementation of PHSMs. Regarding long-term trends, monthly varicella incidence declined by 0.009 per 100,000 (P = .284) following the two-dose strategy, though this change was not statistically significant. In contrast, a significant increase of 0.041 per 100,000 (P = .001) was observed after the implementation of PHSMs. Our findings suggest that while the two-dose strategy led to an immediate decline in varicella incidence, it did not demonstrate a statistically significant impact on the long-term upward trend within the study period. This may reflect the time required to achieve sufficient population immunity, limitations in surveillance sensitivity, or other unmeasured ecological factors. PHSMs provided short-term suppression but were insufficient to alter long-term transmission dynamics. Sustained high coverage with the two-dose schedule remains essential, and continued monitoring is warranted.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.